Laurion Capital Management LP - EIGER BIOPHARMACEUTICALS INC ownership

EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 93 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.24 and the average weighting 0.2%.

Quarter-by-quarter ownership
Laurion Capital Management LP ownership history of EIGER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q2 2021$621,000
-61.6%
72,925
-60.1%
0.00%
-66.7%
Q1 2021$1,616,000
-47.8%
182,632
-27.5%
0.01%
-62.5%
Q4 2020$3,097,000
+94.3%
251,961
+120.9%
0.02%
+14.3%
Q1 2019$1,594,000
+211.9%
114,038
+126.5%
0.02%
+133.3%
Q4 2018$511,00050,3420.01%
Other shareholders
EIGER BIOPHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Vivo Capital, LLC 1,787,091$20,462,0006.02%
INTERWEST VENTURE MANAGEMENT CO 1,599,592$18,315,0003.89%
NEXTHERA CAPITAL LP 263,600$3,018,0001.54%
SPHERA FUNDS MANAGEMENT LTD. 385,301$4,412,0000.86%
RA Capital Management 354,200$4,056,0000.50%
DAFNA Capital Management LLC 35,977$412,0000.35%
Boxer Capital, LLC 138,331$1,584,0000.35%
SABBY MANAGEMENT, LLC 238,907$2,735,0000.15%
Monashee Investment Management LLC 31,500$361,0000.14%
Lombard Odier Asset Management (USA) Corp 100,000$1,145,0000.11%
View complete list of EIGER BIOPHARMACEUTICALS INC shareholders